Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History
International Journal of Clinical Pharmacology & Pharmacotherapy Volume 1 (2016), Article ID 1:IJCPP-120, 3 pages
https://doi.org/10.15344/2456-3501/2016/120
Commentary
The Past, Current, and Future Application of Cryopreserved Human Hepatocytes in Drug Development

Xiao Mei Zhuang1 and Chuang Lu2*

1State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China
2Department of Drug Metabolism and Disposition, Sanofi, Massachusetts, USA
Dr. Chuang Lu, Department of Drug Metabolism and Disposition, Sanofi, 153 second Avenue, Waltham, MA 02451, USA, Tel: 978- 257-9401; E-mail: chuanglu7@gmail.com
04 December 2016; 15 December 2016; 17 December 2016
Zhuang XM, Lu C (2016) The Past, Current, and Future Application of Cryopreserved Human Hepatocytes in Drug Development. Int J Clin Pharmacol Pharmacother 1: 120. doi: https://doi.org/10.15344/2456-3501/2016/120
© 2016 Zhuang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Shitara Y, Li AP, Kato Y, Lu C, Ito K, et al. (2003) Function of uptake transporters for taurocholate and estradiol 17beta-D-glucuronide in cryopreserved human hepatocytes. Drug Metab Pharmacokinet 18: 33-41 [CrossRef] [Google Scholar] [PubMed]
  2. Guengerich FP (2006) Cytochrome P450s and other enzymes in drug metabolism and toxicity. AAPS J 8: E101-111 [CrossRef] [Google Scholar] [PubMed]
  3. FDA (2012) Guidance for Industry Drug Interaction Studies-Study Design, Data Analysis, Implications for Dosing, and Labeling Recommendations
  4. Berry MN, Friend DS (1969) High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol 43: 506-520 [CrossRef] [Google Scholar] [PubMed]
  5. Bojar H, Basler M, Fuchs F, Dreyfürst R, Staib W, et al. (1976) Preparation of parenchymal and non-parenchymal cells from adult human liver-- morphological and biochemical characteristics. J Clin Chem Clin Biochem 14: 527-532 [CrossRef] [Google Scholar] [PubMed]
  6. Fry JR (1982) The metabolism of drugs by isolated hepatocytes. Q Rev Drug Metab Drug Interact 4: 99-122 [CrossRef] [Google Scholar] [PubMed]
  7. Loretz LJ, Li AP, Flye MW, Wilson AG (1989) Optimization of cryopreservation procedures for rat and human hepatocytes. Xenobiotica 19: 489-498 [CrossRef] [Google Scholar] [PubMed]
  8. Li AP, Roque MA, Beck DJ, Kaminski DL (1992) Isolation and culturing of hepatocytes from human liver. J Tiss Culture Methods 14:139-146 [Google Scholar]
  9. Ruegg CE, Silber PM, Mughal RA, Ismail J, Lu C, et al. (1997) Cytochrome-P450 induction and conjugated metabolism in primary human hepatocytes after cryopreservation. In Vitro Toxicol 10: 217-222 [Google Scholar]
  10. Li AP, Lu C, Brent JA, Pham C, Fackett A, et al. (1999) Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential. Chem Biol Interact 121: 17-35 [CrossRef] [Google Scholar] [PubMed]
  11. Huang SM, Strong JM, Zhang L, Reynolds KS, Nallani S, et al. (2008) New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process. J Clin Pharmacol 48: 662-670 [CrossRef] [Google Scholar] [PubMed]
  12. Lu C, Li P, Gallegos R, Uttamsingh V, Xia CQ, et al. (2006) Comparison of intrinsic clearance in liver microsomes and hepatocytes from rats and humans, Evaluation of free fraction and uptake in hepatocytes. Drug MetabDispos 34: 1600-1605 [CrossRef] [Google Scholar] [PubMed]
  13. Shibata Y, Takahashi H, Chiba M, Ishii Y (2002) Prediction of hepatic clearance and availability by cryopreserved human hepatocytes: an application of serum incubation method. Drug Metab Dispos 30: 892-896 [CrossRef] [Google Scholar] [PubMed]
  14. Bachmann K, Byers J, Ghosh R (2003) Prediction of in vivo hepatic clearance from in vitro data using cryopreserved human hepatocytes. Xenobiotica 33: 475-483 [CrossRef] [Google Scholar] [PubMed]
  15. Blanchard N, Hewitt NJ, Silber P, Jones H, Coassolo P, et al. (2006) Prediction of hepatic clearance using cryopreserved human hepatocytes: a comparison of serum and serum-free incubations. J Pharm Pharmacol 58: 633-641 [CrossRef] [Google Scholar] [PubMed]
  16. Skaggs SM, Foti RS, Fisher MB (2006) A streamlined method to predict hepatic clearance using human liver microsomes in the presence of human plasma. J Pharmacol Toxicol Methods 53: 284-290 [CrossRef] [Google Scholar] [PubMed]
  17. Lu C, Miwa GT, Prakash SR, Gan LS, Balani SK (2007) A novel model for the prediction of drug-drug interactions in humans based on in vitro cytochrome p450 phenotypic data. Drug Metab Dispos 35: 79-85 [CrossRef] [Google Scholar] [PubMed]
  18. Lu C, Berg C, Prakash SR, Lee FW, Balani SK (2008a) Prediction of pharmacokinetic drug-drug interactions using human hepatocyte suspension in plasma and Cytochrome P450 phenotypic data. II. In Vitroin Vivo Correlation with ketoconazole. Drug Metab Dispos 36: 1255-1260 [CrossRef] [PubMed]
  19. Lu C, Hatsis P, Berg C, Lee FW, Balani SK (2008b) Prediction of pharmacokinetic drug-drug interactions using human hepatocyte suspension in plasma and Cytochrome P450 phenotypic data. III. In Vitroin Vivo Correlation with fluconazole. Drug Metab Dispos 36: 1261-1266 [CrossRef] [Google Scholar] [PubMed]
  20. Mao JL, Mohutsky MA, Harrelson JP, Wrighton SA, Hall SD (2012) Predictions of Cytochrome P450-mediated drug-drug interactions using cryopreserved human hepatocytes: comparison of plasma and protein-free media incubation conditions. Drug Metab Dispos 40: 706-716 [CrossRef] [Google Scholar] [PubMed]
  21. Mao JL, Johnson TR, Shen ZZ and Yamazaki SJ (2013) Prediction of crizotinib-nidazolam interaction using the Simcyp population-based simulator: comparison of CYP3A time-dependent Inhibition between human liver microsomes versus hepatocytes. Drug Metab Dispos 41: 343-352 [CrossRef] [Google Scholar] [PubMed]
  22. Liu X, LeCluyse EL, Brouwer KR, Gan L-SL, Lemasters JJ, et al. (1999a) Biliary excretion in primary rat hepatocytes cultured in a collagen-sandwich configuration. Am J Physiol 277: G12-G21 [CrossRef] [Google Scholar] [PubMed]
  23. Liu X, LeCluyse EL, Brouwer KR, Lightfoot RM, Lee JI, et al. (1999) Use of Ca2+ modulation to evaluate biliary excretion in sandwich-cultured rat hepatocytes. J Pharmacol Exp Ther 289: 1592-1599 [Google Scholar] [PubMed]
  24. Guo C, Yang K, Brouwer KR, St Claire RL, Brouwer KL (2016) Prediction of altered bile acid disposition due to inhibition of multiple transporters: An integrated approach using sandwich-cultured hepatocytes, mechanistic modeling, and simulation. J Pharmacol Exp Ther. 358: 324-333 [CrossRef] [Google Scholar] [PubMed]
  25. Yang K, Guo C, Woodhead JL, St Claire RL, Watkins PB, et al. (2016) Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury. J Pharm Sci 105: 443-459 [CrossRef] [Google Scholar] [PubMed]
  26. Zhuang XM, Shen GL, Xiao WB, Tan Y, Lu C, et al. (2013) Assessment of the roles of P-glycoprotein and cytochrome P450 in triptolide-induced liver toxicity in sandwich-cultured rat hepatocyte model. Drug Metab Dispos 41: 2158-2165 [CrossRef] [Google Scholar] [PubMed]
  27. Schepers A, Li C, Chhabra A, Seney BT, Bhatia S (2016) Engineering a perfusable 3D human liver platform from iPS cells. Lab Chip 16: 2644-2653 [CrossRef] [Google Scholar] [PubMed]
  28. Nguyen DG, Funk J, Robbins JB, Crogan-Grundy C, Presnell SC, et al. (2016) Bioprinted 3D primary liver tissues allow assessmentof organ-level responseto clinical drug induced toxicity in vitro. PLoSONE 11: e0158674 [CrossRef] [Google Scholar] [PubMed]
  29. Bell CC, Hendriks DF, Moro SM, Ellis E, Walsh J, et al. (2016) Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease. Sci Rep 6: 25187 [CrossRef] [Google Scholar] [PubMed]
  30. Schaefer M, Schänzle G, Bischoff D, Süssmuth RD (2016) Upcyte Human Hepatocytes: a Potent In Vitro Tool for the Prediction of Hepatic Clearance of Metabolically Stable Compounds. Drug Metab Dispos 44: 435-444 [CrossRef] [Google Scholar] [PubMed]
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.